NO170810C - Monoklonalt antistoff av igm-klassen for bruk in vitro ogfremgangsmaate for in vitro deteksjon og diagnose av cancer eller cystisk fibrose - Google Patents

Monoklonalt antistoff av igm-klassen for bruk in vitro ogfremgangsmaate for in vitro deteksjon og diagnose av cancer eller cystisk fibrose

Info

Publication number
NO170810C
NO170810C NO861577A NO861577A NO170810C NO 170810 C NO170810 C NO 170810C NO 861577 A NO861577 A NO 861577A NO 861577 A NO861577 A NO 861577A NO 170810 C NO170810 C NO 170810C
Authority
NO
Norway
Prior art keywords
vitro
monoclonal antibody
fibrose
cystic
diagnosis
Prior art date
Application number
NO861577A
Other languages
English (en)
Norwegian (no)
Other versions
NO170810B (no
NO861577L (no
Inventor
Lana Grauer
Joy Koda
Julia Leung
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of NO861577L publication Critical patent/NO861577L/no
Publication of NO170810B publication Critical patent/NO170810B/no
Publication of NO170810C publication Critical patent/NO170810C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1063—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from stomach or intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO861577A 1985-04-22 1986-04-22 Monoklonalt antistoff av igm-klassen for bruk in vitro ogfremgangsmaate for in vitro deteksjon og diagnose av cancer eller cystisk fibrose NO170810C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72620285A 1985-04-22 1985-04-22

Publications (3)

Publication Number Publication Date
NO861577L NO861577L (no) 1986-10-23
NO170810B NO170810B (no) 1992-08-31
NO170810C true NO170810C (no) 1992-12-09

Family

ID=24917624

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861577A NO170810C (no) 1985-04-22 1986-04-22 Monoklonalt antistoff av igm-klassen for bruk in vitro ogfremgangsmaate for in vitro deteksjon og diagnose av cancer eller cystisk fibrose

Country Status (9)

Country Link
EP (1) EP0200464B1 (fr)
JP (1) JPS61289897A (fr)
AT (1) ATE79632T1 (fr)
AU (2) AU599589B2 (fr)
DE (1) DE3686438T2 (fr)
DK (1) DK185086A (fr)
ES (2) ES8800604A1 (fr)
FI (1) FI87141C (fr)
NO (1) NO170810C (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
NZ222509A (en) * 1986-11-19 1993-03-26 Oncogen Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen
JPS63157995A (ja) * 1986-12-18 1988-06-30 Kyowa Hakko Kogyo Co Ltd 抗ヒト大腸癌単クロ−ン性抗体ａｃｃ−５７４
DK169987D0 (da) * 1987-04-03 1987-04-03 Jens Christian Jensenius Human tumor-associated antigen, ca-ou1
JP2688824B2 (ja) * 1987-05-29 1997-12-10 郁男 山科 単クローン抗体ｎｋｙ１３
US5073493A (en) * 1987-05-29 1991-12-17 Ikuo Yamashina Monoclonal antibody nky13
WO1989000050A1 (fr) * 1987-07-02 1989-01-12 Akzo N.V. Antigene identifie par mca 16-88
EP0397419A3 (fr) * 1989-05-10 1991-04-03 Hybritech Incorporated Antigène associé à une tumeur, anticorps, compositions et leurs utilisations
DE69029270T2 (de) * 1989-09-15 1997-03-27 Genetic Systems Corp., Seattle, Wash. HYBRIDOMA CT43, DAS EIN ANTIKöRPER GEGEN EIN MUCINEPITOP VON DARMKREBS ERZEUGT
IT1262954B (it) * 1992-07-03 1996-07-23 Ist Farmacoterapico It Spa Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
US20010055596A1 (en) * 2000-03-24 2001-12-27 Meagher Madeleine Joy Compositions and methods for therapy and diagnosis of colon cancer
ES2468394T3 (es) * 2008-12-18 2014-06-16 Eidia Co., Ltd. Método para el diagnóstico de la fibrosis qu�stica mediante el uso de los niveles de KL-6

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
NZ212419A (en) * 1984-06-25 1988-08-30 Mucan Diagnostics Pty Ltd In vitro diagnostic test for detecting cancer cells producing mucin antigens
DK172686A (da) * 1985-04-22 1986-10-23 Hybritech Inc Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet

Also Published As

Publication number Publication date
NO170810B (no) 1992-08-31
ES8800604A1 (es) 1987-11-16
FI861692L (fi) 1986-10-23
EP0200464B1 (fr) 1992-08-19
EP0200464A2 (fr) 1986-11-05
AU5646986A (en) 1987-10-29
DK185086A (da) 1986-10-23
DE3686438T2 (de) 1993-01-21
ES557680A0 (es) 1989-05-16
ATE79632T1 (de) 1992-09-15
DK185086D0 (da) 1986-04-22
FI87141C (fi) 1992-12-10
NO861577L (no) 1986-10-23
ES8900247A1 (es) 1989-05-16
AU599589B2 (en) 1990-07-26
EP0200464A3 (en) 1988-05-04
DE3686438D1 (de) 1992-09-24
FI861692A0 (fi) 1986-04-22
FI87141B (fi) 1992-08-31
ES554209A0 (es) 1987-11-16
JPS61289897A (ja) 1986-12-19
AU6556990A (en) 1991-01-17
AU627084B2 (en) 1992-08-13

Similar Documents

Publication Publication Date Title
ATE101202T1 (de) Antikoerper.
NZ222309A (en) Antibodies (including chimeric antibodies) to a human tumour antigen, polynucleotides encoding them, detection of the antigen by immunoassay and imaging methods and also cell killing methods
NO175944C (no) Monoklonale antistoffer for anvendelse til in vitro påvisning av tumorassosiert mucinantigen, og hybridomcellelinjer som produserer disse
NO170810C (no) Monoklonalt antistoff av igm-klassen for bruk in vitro ogfremgangsmaate for in vitro deteksjon og diagnose av cancer eller cystisk fibrose
DE3687736D1 (de) Monoklonale antikoerper gegen humanen brustkrebs, korrespondierende hybridome, deren herstellung und verwendung.
DE3483054D1 (de) Monoklonale antikoerper gegen humane brustkarzinomzellen und ihre verwendung in der diagnose und therapie.
ES8705975A1 (es) Un metodo de deteccion o localizacion de celulas de carcinoma humano.
GR1000454B (el) Νεο μονοκλωνικο αντισωμα κατα νεου αντιγονου που σχετιζεται με ανθρωπινους ογκους.
DE3852054D1 (de) Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung.
ATE132629T1 (de) Harnwegstumor-assoziiertes antigen, verwendung von antigenen untereinheiten und nachweisverfahren
ES8800603A1 (es) Un metodo para producir anticuerpos monoclonales
FI900230A0 (fi) Anti-idiotypa antikroppar mot antikroppar mot antigener med hoeg molekylvikt associerade till human melanoma.
ES8707863A1 (es) Un procedimiento para producir un anticuerpo monoclonal para carcinoma de pulmon humano de celulas no pequenas.
ATE86261T1 (de) Tumorassoziiertes antigen.
ATE92081T1 (de) Tumorassoziiertes antigen.
WO1991017187A3 (fr) ANTIGENE PROTEIQUE ASSOCIE A UNE TUMEUR DE 35 kD: EMPLOIS ET PROCEDES DE DETECTION
EP0397419A3 (fr) Antigène associé à une tumeur, anticorps, compositions et leurs utilisations
GR890100333A (en) Antihuman antigen antibodies